manicmums.com

Time to first NSAID post index date stratified by CV-event diagnosis at

4.9 (411) · $ 18.00 · In stock

Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly

Simultaneous assessment of short‐term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: An instrumental variable analysis - Schneeweiss - 2006 - Arthritis

Cardiovascular and Noncardiovascular Prescribing and Mortality After Takotsubo: Comparison With Myocardial Infarction and General Population

Postdiagnostic intake of a more proinflammatory diet is associated with a higher risk of recurrence and all-cause mortality in colorectal cancer survivors - ScienceDirect

2023: The year in cardiovascular disease – the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?

Understanding Post-Acute Sequelae of SARS-CoV-2 Infection through Data-Driven Analysis with Longitudinal Electronic Health Records: Findings from the RECOVER Initiative

Coronary interventions in 2020: the year in review

Frontiers Soluble interleukin-2 receptor combined with interleukin-8 is a powerful predictor of future adverse cardiovascular events in patients with acute myocardial infarction

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study

Managing Anticoagulation and Dual Antiplatelet Therapy in Patients with Active Bleed or Upcoming Procedure: A Scoping Review

Jose HERNANDEZ, Associate Adjunct Professor

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

ars.els-cdn.com/content/image/1-s2.0-S277237472200

7. Treatment - Canadian Cardiovascular Society